NASH Observatory

⏿ The PanNASH Initiative is an interactive web-based platform presenting global NASH statistics to inform NASH control and research.

NASH: prevalence and incidence of non-liver comorbidities in South Korea

Using a meta-analytic approach, J. Park et al. (Santa Clara Valley Medical Center, San Jose, CA, USA) aimed to describe NAFLD incidence and prevalence, NAFLD fibrosis prevalence, and incidence of non-liver comorbidities. In this study, the overall prevalence of NAFLD was 31.46% with an incidence rate of 42.8 per 1,000 person-years...
Read MoreNASH: prevalence and incidence of non-liver comorbidities in South Korea

Evidence linking obesity with MAFLD, NASH, and CVD

Several studies provide evidence for an association between MAFLD and atherosclerosis and cardio-metabolic disorders, including cardiovascular diseases such as coronary heart disease and stroke. Therefore, the combination of MAFLD/NASH is associated with vascular risk and CVD progression, but the underlying mechanisms...
Read MoreEvidence linking obesity with MAFLD, NASH, and CVD

Treatments for NAFLD: different available approaches

General strategies have been proposed to manage NAFLD. They include: (a) lifestyle change in order to promote weight loss by diet and physical activity, (b) control of the main cardiometabolic risk factors, (c) correction of all modifiable risk factors leading the development and progression of advanced forms of NAFLD, (d) and prevention...
Read MoreTreatments for NAFLD: different available approaches

Mediterranean dietary pattern and non-alcoholic fatty liver diseases: a case-control study

A few studies investigated the Mediterranean diet in developing countries, especially middle east countries where dietary patterns are different from other parts of the world. This case-control study aimed to examine the association between adherence to the Mediterranean diet and NAFLD in Iranian adults...
Read MoreMediterranean dietary pattern and non-alcoholic fatty liver diseases: a case-control study